Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 59

1.

A comparison of EuroQol 5-Dimension health-related utilities using Italian, UK, and US preference weights in a patient sample.

Mozzi A, Meregaglia M, Lazzaro C, Tornatore V, Belfiglio M, Fattore G.

Clinicoecon Outcomes Res. 2016 Jun 13;8:267-74. doi: 10.2147/CEOR.S98226. eCollection 2016.

2.

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)., Dowsett M, Forbes JF, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes RC, Cuzick J, Dubsky P, Gnant M, Kaufmann M, Kilburn L, Perrone F, Rea D, Thürlimann B, van de Velde C, Pan H, Peto R, Davies C, Gray R.

Lancet. 2015 Oct 3;386(10001):1341-52. doi: 10.1016/S0140-6736(15)61074-1. Epub 2015 Jul 23.

3.

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)., Coleman R, Powles T, Paterson A, Gnant M, Anderson S, Diel I, Gralow J, von Minckwitz G, Moebus V, Bergh J, Pritchard KI, Bliss J, Cameron D, Evans V, Pan H, Peto R, Bradley R, Gray R.

Lancet. 2015 Oct 3;386(10001):1353-61. doi: 10.1016/S0140-6736(15)60908-4. Epub 2015 Jul 23. Erratum in: Lancet. 2016 Jan 2;387(10013):30.

4.

Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

EBCTCG (Early Breast Cancer Trialists' Collaborative Group)., McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S.

Lancet. 2014 Jun 21;383(9935):2127-35. doi: 10.1016/S0140-6736(14)60488-8. Epub 2014 Mar 19. Erratum in: Lancet. 2014 Nov 22;384(9957):1848.

5.

[ProMoFIA_Oncologic: monitoring project of the innovative oncology drugs in Abruzzo].

Belfiglio M, Sichetti D, Romero M, Orsini A; Gruppo di lavoro ProMoFIA_Oncologici..

Recenti Prog Med. 2013 Jun;104(6):241-5. doi: 10.1701/1295.14324. Italian.

PMID:
23801227
6.

Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer.

Bandieri E, Sichetti D, Romero M, Fanizza C, Belfiglio M, Buonaccorso L, Artioli F, Campione F, Tognoni G, Luppi M.

Ann Oncol. 2012 Aug;23(8):2016-20. doi: 10.1093/annonc/mds103. Epub 2012 May 6.

PMID:
22565123
7.

Hospital discharge database as a tool to monitor incidence, survival and burden of cancer in adolescents and young adults.

Scurti V, Di Ienno S, Fanizza C, Belfiglio M, D'Ettorre A, Romero M, Tognoni G.

Tumori. 2012 Jan-Feb;98(1):19-26. doi: 10.1700/1053.11495.

PMID:
22495697
8.

Meta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancer.

Belfiglio M, Fanizza C, Tinari N, Ficorella C, Iacobelli S, Natoli C; Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO)..

J Cancer Res Clin Oncol. 2012 Feb;138(2):221-9. doi: 10.1007/s00432-011-1091-0. Epub 2011 Nov 18. Review.

9.

Gemcitabine-induced posterior reversible encephalopathy syndrome: a case report.

Cioffi P, Laudadio L, Nuzzo A, Belfiglio M, Petrelli F, Grappasonni I.

J Oncol Pharm Pract. 2012 Jun;18(2):299-302. doi: 10.1177/1078155211424628. Epub 2011 Nov 7.

PMID:
22065198
10.

The impact of a pharmacist as a member of healthcare team on facilitating evidenced-based prescribing of innovative drugs in an Italian oncology department.

Cioffi P, Antonelli D, Belfiglio M, Melena S, Petrelli F, Grappasonni I.

J Oncol Pharm Pract. 2012 Jun;18(2):207-12. doi: 10.1177/1078155211424787. Epub 2011 Oct 21.

PMID:
22020659
11.

Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)., Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R.

Lancet. 2011 Nov 12;378(9804):1707-16. doi: 10.1016/S0140-6736(11)61629-2. Epub 2011 Oct 19. Review.

12.

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)., Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R.

Lancet. 2011 Aug 27;378(9793):771-84. doi: 10.1016/S0140-6736(11)60993-8. Epub 2011 Jul 28.

13.

Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.

Genovesi D, Cèfaro GA, Vinciguerra A, Augurio A, Di Tommaso M, Marchese R, Ricardi U, Filippi AR, Girinsky T, Di Biagio K, Belfiglio M, Barbieri E, Valentini V.

Strahlenther Onkol. 2011 Jun;187(6):357-66. doi: 10.1007/s00066-011-2221-y. Epub 2011 May 16.

PMID:
21603989
14.

Research trends for early cancer biomarker detection in Italy: an integrated program in oncology (PIO) survey.

Verderio P, Mangia A, Orlando C, Belfiglio M, Marchetti A, Bertario L, Chiappetta G, Gion M, Tonini GP, Podo F, Vocaturo A, Silvestrini R, Lombardo C, Paradiso A.

Tumori. 2010 Sep-Oct;96(5):721-5.

15.

Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanoma.

Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Lucisano G, Labianca R, Marchesi L, Merelli B, Robone S, Poletti P, Milesi L, Tondini C.

Mayo Clin Proc. 2011 Feb;86(2):113-9. doi: 10.4065/mcp.2010.0671.

16.

Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG)., Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, Peto R, Bijker N, Solin L, Darby S.

J Natl Cancer Inst Monogr. 2010;2010(41):162-77. doi: 10.1093/jncimonographs/lgq039. Review.

17.

Is pain in patients with haematological malignancies under-recognised? The results from Italian ECAD-O survey.

Bandieri E, Sichetti D, Luppi M, Di Biagio K, Ripamonti C, Tognoni G, Belfiglio M, Romero M.

Leuk Res. 2010 Dec;34(12):e334-5. doi: 10.1016/j.leukres.2010.08.013. Epub 2010 Sep 21. No abstract available.

PMID:
20863565
18.

The ATAC adjuvant breast-cancer trial: six-year results of the endometrial subprotocol.

Duffy S, Jackson TL, Lansdown M, Philips K, Wells M, Clack G, Bianco AR; ATAC Trialists' Group..

J Obstet Gynaecol. 2010;30(6):596-604. doi: 10.3109/01443615.2010.492433.

PMID:
20701510
19.

Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance.

Parmelli E, Papini D, Moja L, Bandieri E, Belfiglio M, Ciccone G, De Palma R, Leoni M, Longo G, Magrini N, Moschetti I, Liberati A.

Ann Oncol. 2011 Jan;22(1):188-94. doi: 10.1093/annonc/mdq324. Epub 2010 Jul 6.

PMID:
20605933
20.

[Memorandum for the management of clinical trials].

Valentini M, Pirozzoli MC, D'Alonzo D, Pirozzi L, Anecchino C, Tuzi F, Romero M, Nicolucci A, Strippoli GF, Belfiglio M, Marchioli R, Masciulli A, Silletta MG, Tognoni G; Gruppo di lavoro sulla sperimentazione clinica..

Assist Inferm Ric. 2010 Jan-Mar;29(1):26-40. Italian.

PMID:
20514810

Supplemental Content

Loading ...
Support Center